FDA classifies this as a Class I recall, which means using the device could result in adverse health effects or death. Dexcom Inc., has recalled its G4 Platinum and G5 Mobile continuous glucose ...

This is a Class I recall where 56 serious injuries have been reported. If you use one of Dexcom's continuous glucose monitoring systems, here's what you need to know. Taylor Leamey wrote about all ...

The Dexcom G4 receiver, which will have an "identical" form factor to the forthcoming Bluetooth version. In a call to investors days after its app won FDA approval, Dexcom CEO Kevin Sayer shared some ...

Continuous glucose monitor company Dexcom has hit a stumbling block. Some of its devices, including the G5 receiver for a system that just launched last fall, are not providing the audio alarms and ...

Dexcom has received approval from the FDA for a new version of its smartphone connected Dexcom Share platform that will eliminate the docking cradle and allow a patient's continuous glucose monitor ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Dexcom Inc. issued a recall of its ...

The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and ...

The FDA has approved updat- ed, more accurate software for the Dexcom G4 Platinum pediatric continuous glucose monitoring (CGM) system. The approval, granted May 22, 2015, reflects soft-ware changes ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc., (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug ...

Tech Times announced our 2015 CES Best of Innovation Honorees and the list of winners included everything from Samsung's ultra-thin and powerful Series 9 2015 Edition Ultrabook to LG's 4K Ultra HD TV ...

A new study of Dexcom's G4 Platinum continuous glucose monitor showed that more than half of the participants experienced a 10% or higher reduction in an important indicator for developing ...

As med tech outfits race to develop innovative, noninvasive technology for diabetes monitoring, Dexcom ($DXCM) snagged FDA approval for a new artificial pancreas ...